Achieve Life Sciences (ACHV) Director Martin Nathan Receives Awards

What Happened

• Martin Christopher Nathan, a director of Achieve Life Sciences, received two equity awards on 2026-07-27: 25,000 derivative options and 16,700 restricted stock units (RSUs), for a total of 41,700 awarded units. The reported per-unit acquisition price is $0.00 (award/grant), so no cash changed hands at grant. These are awards (compensation), not open-market purchases or sales.

Key Details

• Transaction date: 2026-07-27; Form 4 filed 2026-07-29 (filed within the normal two-business-day window).
• Awards: 25,000 options (derivative) and 16,700 RSUs (derivative); combined = 41,700 units. Reported price: $0.00.
• Vesting: Options vest 100% on the earlier of July 27, 2027 or immediately prior to the issuer’s 2027 annual meeting, subject to continued service (Footnote F1). Each RSU represents a contingent right to one common share and vests 100% on the same schedule, subject to continued service (Footnotes F2, F3).
• Shares owned after transaction: not specified in the provided data.
• Transaction code: A = Award/Grant. No 10b5-1 plan, tax-withholding sale, or cashless exercise noted in the filing.

Context

• These are compensation awards to a director and do not represent an immediate cash investment or sale. RSUs convert to actual shares only upon settlement after vesting; options may require exercise per plan terms. Such awards are common for board compensation and should be viewed as granted incentives rather than an immediate market signal.